Legislation: Plant vs. Drug
##plugins.themes.bootstrap3.article.main##
Abstract
Enacting laws that impact everyone’s health is an obligation of the modern state. It is a highly nuanced, idealistic mandate, involving a legislative and technical path riddled with pitfalls and therefore fraught with danger. This is precisely what has happened with the legislative process to ensure legal certainty regarding the use, production, transportation, and marketing of the two forms of marijuana and its alkaloids: “medicinal” and “recreational.”
References
Smith, A., Kaufman, F., Sandy, M. S., & Cardenas, A. (2020). Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease. Current Environmental Health Reports, 7(3), 325-342. https://doi.org/10.1007/s40572-020-00275-4
Vaucher, J., Keating, B. J., Lasserre, A. M., Gan, W., Lyall, D. M., Ward, J., Smith, D. J., Pell, J. P., Sattar, N., Paré, G., & Holmes, M. V. (2017). Cannabis use and risk of schizophrenia: a Mendelian randomization study. Molecular Psychiatry, 23(5), 1287-1292. https://doi.org/10.1038/mp.2016.252
Dictamen de las Comisiones Unidas de Justicia y de Salud de la Minuta con Proyecto de Decreto por el que se expide la Ley Federal para la Regulación del Cannabis y reforma y adiciona diversas disposiciones de la Ley General de Salud y del Código Penal Federal. Gaceta Parlamentaria, no. 5736-II, Cámara de Diputados, LXIV Legislatura. 10 de marzo de 2021, (México). https://gaceta.diputados.gob.mx/PDF/64/2021/mar/20210310-II.pdf
Hurd, Y. L., Manzoni, O. J., Pletnikov, M. V., Lee, F. S., Bhattacharyya, S., & Melis, M. (2019). Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects. The Journal of Neuroscience, 39(42), 8250-8258. https://doi.org/10.1523/jneurosci.1165-19.2019
